The store will not work correctly when cookies are disabled.
(Z)-3-(2-(3-chlorophenyl)-2-oxoethylidene)-3,4-dihydroquinoxalin-2(1H)-one
ID: ALA4777530
PubChem CID: 135453970
Max Phase: Preclinical
Molecular Formula: C16H11ClN2O2
Molecular Weight: 298.73
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1Nc2ccccc2N/C1=C\C(=O)c1cccc(Cl)c1
Standard InChI: InChI=1S/C16H11ClN2O2/c17-11-5-3-4-10(8-11)15(20)9-14-16(21)19-13-7-2-1-6-12(13)18-14/h1-9,18H,(H,19,21)/b14-9-
Standard InChI Key: YSEBPFBXVWYGRO-ZROIWOOFSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
1.2244 -15.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2244 -16.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9313 -16.7303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6381 -16.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6381 -15.4982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9295 -15.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3494 -15.0844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0628 -15.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0628 -16.3255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3470 -16.7348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7671 -16.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7671 -17.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4737 -17.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4737 -18.7799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1734 -19.1905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8801 -18.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8801 -17.9622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1766 -17.5556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1734 -20.0076 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.0582 -17.9598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7727 -15.0934 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
5 4 1 0
5 6 2 0
6 1 1 0
5 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
4 10 1 0
9 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
17 16 1 0
18 17 2 0
18 13 1 0
15 19 1 0
12 20 2 0
8 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.73 | Molecular Weight (Monoisotopic): 298.0509 | AlogP: 3.47 | #Rotatable Bonds: 2 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.91 | CX Basic pKa: ┄ | CX LogP: 2.69 | CX LogD: 2.69 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.66 | Np Likeness Score: -0.76 |
References
1. Dou X,Huang H,Jiang L,Zhu G,Jin H,Jiao N,Zhang L,Liu Z,Zhang L. (2020) Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors., 201 [PMID:32603981] [10.1016/j.ejmech.2020.112445] |